ArticleIn vivo (Athens, Greece)

Real-world Feasibility of Adjuvant Nivolumab for High-risk Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.

Masaaki Yanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.